These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38637657)

  • 1. The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
    Lawson H; Holt-Martyn JP; Dembitz V; Kabayama Y; Wang LM; Bellani A; Atwal S; Saffoon N; Durko J; van de Lagemaat LN; De Pace AL; Tumber A; Corner T; Salah E; Arndt C; Brewitz L; Bowen M; Dubusse L; George D; Allen L; Guitart AV; Fung TK; So CWE; Schwaller J; Gallipoli P; O'Carroll D; Schofield CJ; Kranc KR
    Nat Cancer; 2024 Jun; 5(6):916-937. PubMed ID: 38637657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
    Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance.
    Vukovic M; Guitart AV; Sepulveda C; Villacreces A; O'Duibhir E; Panagopoulou TI; Ivens A; Menendez-Gonzalez J; Iglesias JM; Allen L; Glykofrydis F; Subramani C; Armesilla-Diaz A; Post AE; Schaak K; Gezer D; So CW; Holyoake TL; Wood A; O'Carroll D; Ratcliffe PJ; Kranc KR
    J Exp Med; 2015 Dec; 212(13):2223-34. PubMed ID: 26642852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
    HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
    Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
    BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells.
    Caprara V; Scappa S; Garrafa E; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2014 Nov; 118(2):185-90. PubMed ID: 24607784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
    Appelhoff RJ; Tian YM; Raval RR; Turley H; Harris AL; Pugh CW; Ratcliffe PJ; Gleadle JM
    J Biol Chem; 2004 Sep; 279(37):38458-65. PubMed ID: 15247232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
    Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMOG ameliorates IFN-γ-induced intestinal barrier dysfunction by suppressing PHD2-dependent HIF-1α degradation.
    Wang WS; Liang HY; Cai YJ; Yang H
    J Interferon Cytokine Res; 2014 Jan; 34(1):60-9. PubMed ID: 24010824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
    Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
    Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
    Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
    Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein.
    Park YG; Moon JH; Park SY
    Neuroscience; 2014 Aug; 274():187-97. PubMed ID: 24875174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
    Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
    J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M
    Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications.
    Kim SY; Yang EG
    Molecules; 2015 Nov; 20(11):20551-68. PubMed ID: 26610437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.